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NEWCOMER to The Rockefeller University 
campus on Manhattan's upper East Side 
would have some difficulty identifying the 
Hospital. Only the decorative use of the ca­
duceus on the red brick exterior furnishes a clue. Oth­
erwise the Hospital shares the architectural f ea tu res of 
the older buildings on campus, built in the opening dec­
ades of this century after the founding of the U �iversity 
in 1 go 1 as The Rockefeller Institute for Medical Research. 
The Hospital's physical integration into this compact 
cluster of buildings is symbolic of its traditionally close 
relationship to the institution as a whole, one of the few 
in the world today engaged exclusively in scientific re­
search and graduate education in the biomedical sciences 
and in related behavioral and physical sciences. 
A Pioneer in Biomedical Science 
The Rockefeller Institute was established by John D. 
Rockefeller, Sr., in response to the pressing need for 
biomedical research facilities in this country. At that 
time, young American physicians bent on scientific ca­
reers went to Europe to obtain laboratory training. The 
objective of the new institute was to benefit mankind 
through basic research and its application to, the under­
standing, treatment, and prevention of disease. In carry­
ing out that objective, The Rockefeller has been a major 
force in bringing the United States to the forefront of 
the biological and medical sciences. It has also served as 
a model for the establishment of similar research centers. 
From its beginnings, scientists have been attracted to the 
institution from all parts of the world, and many young 
M.D.'s and Ph.D.'s have come here for advanced train­
ing. In 1954, the Institute became a graduate university,
and the first Ph.D. degrees were granted in 1959. In
1965, its name was changed to The Rockefeller University.
Com pared to general purpose universities, this ins ti-
tution is modest in size. Its 15-acre campus is the base for 
a scientific community ofabout 1,450 people -2 50 regular 
faculty, 200 postdoctoral fellows and research associates, 
1 oo graduate students, and a staff of about goo, including 
laboratory technicians, nurses, instrument makers, elec­
tronics specialists, and other supporting and administra­
tive personnel. 
A Wide Freedom of Inquiry 
The University has an administrative structure built 
around more than 50 laboratory groups, a few compris­
ing a single scholar and the rest ranging from groups of 
3 to more than 35 persons, including students. Although 
the laboratory groups represent a great diversity of sci­
entific fields, from theoretical physics to behavioral sci­
ence, individual investigators are encouraged to cross 
disciplinary lines and pursue overlapping interests with 
their colleague� in other groups. There are no traditional 
departmental boundaries. Rockefeller scientists enjoy a 
wide freedom of inquiry and set their own research 
goals. Out of this unique organization has come a series 
of achievements that, directly or indirectly, have bene­
fited the lives of people throughout the world and have 
influenced the development of some of the most impor­
tant fields in the life sciences. 
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HE ROCKEFELLER HOSPITAL has the same 
rganizational flexibility as have the other Uni­
ersity laboratories and, since 1 g 1 o when its 
doors were first opened· to patients, it has. op­
erated in exactly the same spirit. Rufus Cole, its first 
director, insisted that the Hospital should be staffed by 
full-time salaried physicians working in their own lab­
oratories, but strongly supported by and free to collab­
orate with the other institutional laboratories. Cole be­
lieved the real purpose of a research hospital was to 
attempt to understand the normal physiological char­
acteristics of human beings, in order better to analyze 
the derangements that occur in disease. In 1910, these 
were original concepts: The Rockefeller Hospital was 
the first clinical research institution where human dis­
ease could be studied and treated in a setting of rigor­
ous, scientific inquiry. 
This unique approach to clinical research made the 
Hospital the pacesetter in revolutionizing academic med­
icine in America. Its impact was critically important in 
upgrading medical education at a time when many med­
ical colleges were no more than trade schools. Most of 
the medical school leaders who moved for reform had 
served "apprenticeships" in clinical research at The 
Rockefeller Hospital. For seven decades, successive gen­
erations of clinical researchers have come to the Hospital 
for advanced training and have moved on to influential 
positions in other institutions. 
In the 1950s, the 40-bed Hospital served as an organiza­
tional model for the federally supported Clinical Center, 
with 500 beds, that was established by the National Insti­
tutes of Health in Bethesda, Md., as well as for the 
smaller clinical research centers set up, with federal 
funding, by more than 80 American medical schools. 
Between Medicine and Biology 
Infectious and nutritional diseases, which were the pre­
dominant lethal or crippling illnesses at the turn of the 
century, were a major focus of concern in the creation of 
the Hospital. Since then, the Hospital has stood at the 
gateway between medicine and biology. The basic, as 
well as the clinical, knowledge that has come from the 
research at the Hospital has dramatically demonstrated 
the importance of the direct study of disease in human 
beings. 
Often the observation of disease led to a clearer 
understanding of life processes; out of this, such new 
scientific disciplines as genetics, cell biology, and immu­
nology have emerged and reached their present major 
status. For example, the nature of bacterial virulence, a 
matter of continuing concern to the clinical investigator, 
spurred pioneering experiments in biochemical ge­
netics, and an important discipline was born. Similarly, 
the prevention of infectious disease was the clinical objec­
tive that promoted the development of immunology; this 
led, in turn, to the discovery of a host of immune-based 
disorders. In still another area, the clinical study of pul­
monary and kidney failure resulted in the invention of 
many basic, now-indispensable tools of biochemistry. 
Perhaps the most dramatic example in the Hospital's 
Entrance to the Hospital. 
history of how the combination of basic and clinical­
research can produce results useful to the practicing 
physician and may also result in basic discoveries that 
significantly expand our understanding of the mecha­
nisms of life is the work of Oswald T. Avery. He and his 
gifted associates were investigating the chemistry of the 
pneumococcus, causative factor of lobar pneumonia, 
when they demonstrated for the first time that DNA is the 
genetic material. Their finding, published in 1944, has 
been considered the central discovery of twentieth-cen­
tury biology. 
Focus on Clinical Investigation 
Today The Rockefeller University Hospital is the largest 
and the only private facility in the country that is devoted 
exclusively to clinical investigation. Its staff consists of 
about 1 o percent of the University's senior faculty mem­
bers and their colleagues. The40-bed unitlogs aboutg,ooo 
inpatient days each year, as well as an additional 5, ooo 
outpatient visits. The patients are drawn not only from 
the New York metropolitan area but also from other 
states and other countries. 
All patients receive the most modern medical care, 
without charge, during often lengthy stays for research 
on and care of their illnesses. Many patients keep in 
touch with the Hospital after their release, either as out­
patients or through their own physicians. Like the faculty 
of the other University laboratories, faculty members at 
the Hospital hold full-time salaried appointments and 
do not charge professional or laboratory fees to patients. 
Though The Rockefeller Hospital carries out many of 
the conventional medical functions of patient care com­
mon to.all hospitals-and prides itself on the high quality 
of that care-these activities are conducted strictly in the 
context of its primary scientific mission. 
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UST as the interests of the University have broad­
ened and deepened in all branches of the basic life 
sciences, so too has the research program of the 
Hospital acquired new dimensions. Like their pre­
decessors, today's investigators, inspired by the con­
cept of human disease as a general biological problem, 
are looking ever more deeply into organic structure and 
function, while at the same time seeking to integrate 
their findings into the "ordered complexity" of animal 
physiology and chemistry. 
The disorders under study today can be divided into 
two broad categori'es-immunology and metabolism. The 
largest percentage of bed use in the Hospital is devoted 
to research on rheumatoid arthritis, systemic lupus ery­
thematosus, and other collagen diseases; problems of 
cholesterol metabolism; acute and chronic glomerulo­
nephritis; obesity; and diabetes. Dermatologic disorders 
and endocrine-related cancer have recently been added 
to the list of chronic disabling diseases under study. The 
Hospital laboratories also are engaged in research on 
rheumatic fever; a variety of genetic disorders, including 
the porphyrias; problems of alcoholism, drug addiction, 
and nutrition; and clinical pharmacology. A recent and 
Campus in spring. 
growing interest is in the area of biocnemical toxicology 
and the impact of environmental chemicals on man. 
Investigators in the Hospital frequently join forces 
with other scientists on campus on work that demands a 
multiplicity of professional skills. In turn, basic research 
programs with potential clinical implications draw upon 
the resources of the Hospital when appropriate. 
Need for Clinical Researchers 
In recent years, there has been a declining interest in 
clinical research among medical students and graduates 
in this country and in most of the western world. If the 
trend is not reversed, the growth of medical knowledge 
in the next generation will be seriously impaired. A key 
step toward the solution of this problem is to provide 
assured opportunities and financial support to gifted 
young physicians, thus encouraging them to consider 
careers in clinical investigation as an alternative to medi­
cal practice. 
Exposure to outstanding physician-scientists, to a dis­
cipline that applies the analytical powers of the modern 
sciences to disease problems, and to an atmosphere of 
collaborative research between basic scientists and clini­
cians is critical to the development of a new generation 
of clinical investigators. The Rockefeller Hospital offers 
such an environment. It is seeking to recruit outstanding 
young physicians who are completing their residency 
programs and are prepared to join the Hospital staff in 
order to train themselves for careers in the clinical sci­
ences. 
Th� Right Environment 
To a select group of such young men and women, The 
Rockefeller Hospital offers full financial support, includ­
ing salary and laboratory facilities, for three or more 
years. These Clinical Scholars are given faculty appoint-
men ts and become full colleagues in the Rockefeller re­
search community. Every effort is made to house them 
near the campus, situated in one of the most coveted 
neighborhoods in New York City. 
Young researchers find an unusually rich range of 
personal and professional associations open to them 
within an institution where almost all of the disciplines 
contiguous to medicine are represented. They share in 
the intimacy and administrative simplicity that are 
among the great strengths of the University and its Hos­
pital. They find colleagues willing to open their labora­
tories to visitors; to expose their ideas to the scrutiny of 
other investigators; to give assistance; and to debate, 
persuade, and teach. These associations are further en­
hanced by ties, formal and informal, that link the Uni­
versity to its immediate neighbors, The New York Hos­
pital-Cornell Medical Center and Memorial Sloan­
Kettering Cancer Center, as well as to other medical 
institutions in New York City. To all this must be added 
the best of music, theater, ballet, art, spectator sports, 
and recreational facilities of all kinds-virtually at the 
doorstep of the University. 
Learning by Experience 
When Clinical Scholars join a laboratory group at the 
Hospital-even if they have had little previous laboratory 
experience-they quickly become familiar with the basic 
research disciplines of that group. In the first year or so, 
they are guided toward a research goal of their own; but 
within the very flexible framework of the group they 
have considerable freedom of choice. They learn by ex­
perience ( since there are no formal courses) to recognize 
investigative challenges, to frame important questions, 
and to design meaningful experiments and perform the 
laboratory work required to answer those questions. At 
least 80 percent of their work day is spent in the labora-
Tower Building plaza with Queensboro Bridge in background . 
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tory. The remainder is devoted to the care of their re­
search patients. 
This division of time points up the real strength of the 
clinical research programs at the Hospital. First, the sci­
entists are not burdened by responsibilities for formal 
teaching, ward service, or administration. Second, each 
investigator can study patients on the metabolic ward for 
extended periods without any demand for tightly struc­
tured protocols, because it is the tradition at the Hospital 
to study small numbers of patients in great detail. Third, 
the clinical situation guides the nature of the questions 
asked and the manner in which the answers are sought; 
the discoveries that result are a measure of the ingenuity 
of the investigator. Having demonstrated mastery of the 
discipline of patient-oriented research, the trained inves­
tigator becomes much sought-after in academic medi­
one. 
A National Resource 
For more than 70 years, the Hospital has served as a na­
tional resource in the study of human disease. It has 
shown itself capable of adapting effectively to a changing 
scientific, academic, and social environment. Its original 
purpose not only remains valid but, in fact, is even more 
important now as federal funding for clinical research 
declines. To ensure against the uncertainties of federal 
grants, The Rockefeller University is now engaged in a 
ten-year development program to broaden its base of 
private financial support. One of the fruits of this effort 
is the funding by the University of the Clinical Scholars 
program and other major projects designed to strengthen 
the Hospital's remarkably productive environment for 
discovery. 
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Bacteriology and Immunology 
This laboratory, headed by Professor Emil C. Gotschlich, has 
spent more than three decades in seeking a greater understand­
ing of the host's relationship to infectious agents and the diseases 
they produce. Among the diseases under study have been those in 
which an established relationship to a known microorganism has 
been demonstrated as well as those diseases in which a presumed 
microbial agent might be involved. In the former category has 
been a study of post-streptococcal sequelae as well as group B 
infections of the newborn. Knowledge of many of the structures 
and functions of hemolytic streptococci has been elucidated. Also, 
a genetic marker in rheumatic fever and a nephritogenic protein 
unique to nephritis strains have been discovered, and the host's 
immune response to microbial infections in these disease states 
has been described. Of equal importance has been the elucidation 
of the role polysaccharides of the meningococcus play in immu­
nity to these infections with the development of active vaccines 
against the group A and C meningococcus. 
Among the diseases in which a presumed infectious agent may 
play a role are rheumatoid arthritis and multiple sclerosis. In the 
' 
former, evidence has accrued indicating a possible relationship 
between bacterial mucopeptide antigens and the disease state. In 
multiple sclerosis, the evidence is inconclusive, but suggests that a 
prior viral event coupled with abnormalities in immunoregulation 
might trigger a neurological lesion. 
Current activities of the laboratory include exploration, in 
experimental models and in man, of the relationship of microbial 
antigens to rheumatoid arthritis. In rheumatic fever, the role of 
the genetic marker in the immune response to streptococcal anti­
gens is being explored. In glomerulonephritis particular empha­
sis is being placed on the role of a nephritogenic protein in acute 
nephritis as well as on pathological mechanisms involved in the 
development of chronic glomerulonephritis. Neuroimmunologi­
cal studies are conc�ntrated on the role of cellular and humoral 
regulatory mechanisms in multiple sclerosis and on a better defi­
nition of the role CNS antigens play in chronic neurological dis­
eases. Concomitant with these studies of pathogenesis is the con­
tinuing basic exploration of bacterial virulence factors important 
in the prevention of known infectious diseases. 
Biology ef Addictive Diseases 
The laboratory of Dr. Mary Jeanne Kreek is engaged in the study 
of the disposition and physiological effects of addictive agents, 
particularly alcohol and narcotics. The goal is to determine fac­
tors that contribute to the initiation and perpetuation of addic­
tion, and influence treatment. 
Current studies focus on the possible roles of chronic liver dis­
ease, prevalent in addicted patients, and of altered endocrine and 
neuroendocrine function, either drug-induced or spontaneous, in 
the occurrence of recidivism following achievement of the drug­
free state and in the initial development of addiction. Using vari­
ous technologies, this laboratory has made the first documenta­
tion of clinically significant interactions between a narcotic and 
any other drug, the initial clinical and laboratory discovery of the 
effects of chronic opioid administration on enhancing albumin 
synthesis, and the first demonstration that the liver acts as a reser­
voir for storage and release of long-acting narcotics. 
In 1964, Professor Vincent P. Dole, Dr. Marie Nyswander, and 
Dr. Kreek introduced pharmacological maintenance treatment of 
narcotic addiction with methadone, an orally effective, long-act­
ing narcotic. Studies conducted at The Rockefeller University 
Hospital showed that such treatment prevents narcotic abstinence 
and drug-seeking behavior and restores patients to a functional 
state. Other studies have shown that chronic methadone treat­
ment is medically safe. Studies of the role of ACTH, beta-endor­
phin, and other hormones in narcotic abstinence and in drug­
seeking behavior of drug-free narcotic addicts and alcoholics are 
in progress. Also being explored is the role of endogenous opioids 
in the normal physiological control of intestinal motility and in 
motility disorders. 
Cellular Physiology andlmmun'ology 
This laboratory is concerned with the roles of leukocytes and their 
products in inflammation, infectious cellular immunity, and 
cancer. Headed by Dr. Zanvil A. Cohn, it includes among its fac­
ulty Drs. Marcus Horwitz, Carl Nathan, Nadia Nogueira, William 
Scott, Samuel Silverstein, Ralph Steinman, and Jay U nkeless. It is 
well known for structural and functional analyses of murine 
macrophages, their secretory products, and the properties of 
their membranes in pinocytosis and phagocytosis. Dendritic cells, 
which play essential roles in T-cell stimulation and transplantation 
immunity, were first purified in this laboratory. 
In the last five years the scope of the laboratory has expanded 
to the study of human cells and diseases, opening up opportuni­
ties for investigations integrating laboratory and clinical research. 
Methods have been developed to purify and culture monocytes 
and dendritic cells from human blood and tissues, and to isolate 
their plasma membrane proteins and receptors using monoclonal 
antibodies. Major disease-related areas under study include: 
a) The role of activated macrophages in host defense against
tumors, Legionnaires' disease bacteria, leprosy, and Trypanosoma 
cruzi. 
b) Tumoricidal and microbicidal properties of reactive oxygen
metabolites (hydrogen peroxide, superoxide anion), and anti­
oxidant def ens es of normal and malignant cells. 
c) Monocyte- and macrophage-derived arachidonic acid me­
tabolites (prostaglandins, leukotrienes) in immediate hypersensi­
tivity and immune suppression. 
d) Biochemistry and functional properties of Fe and comple­
ment receptors. 
e) Differentiation of mononuclear phagocytes.
f) Production of lymphocyte-activating factors by human den­
dritic cells, and the functions of dendritic cells in inflammation 
and arthritis. 
In conjunction with the appropriate divisions at The New 
York Hospital-Cornell Medical Center, this laboratory maintains 
Fellowship Training programs leading to Board qualifications in 
Infectious Diseases and Hematology-Oncology. 
Cutaneous Biology 
and Investigative Dermatology 
Professor D. Martin Carter, formerly at Yale University, has 
established new laboratories at The Rockefeller to explore 
fundamental mechanisms operative in disabling skin diseases. 
His laboratory group has been studying the relative 
contributions of genetic and environmental influences on such 
cutaneous functions as aging and skin cancer. The environmental 
factors that damage DNA are of special interest, and include photo 
injury by ultraviolet irradiation of various wavelengths and by UV 
irradiation combined with such phototoxic drugs as psoralens and 
chlorpromazine. Proliferative cellular responses have been 
characterized in cultured cutaneous fibroblasts exposed to 
psoralens and long-wave UV light. The role of pigment as a 
defense has been demonstrated in cells and in skin, and 
photomediated stimulation by psoralens of pigmentation by way 
of tyrosinase activity also has been demonstrated. Further 
enhancement of photomediated cellular damage by changes in 
temperature and atmospheric oxygen tension are under 
investigation. Cytogenetic consequences of photomediated 
psoralen�DNA damage have been characterized. Sister chromatid 
exchanges (SCEs) have been shown to develop after in vitro
exposure to psoralens and light, and the influences on SCEs of 
DNA binding, K
m
, and DNA-cross-linking potential of various 
psoralens have been shown. The capacity of cutaneous cells to 
repair psoralen-DNA damage is being studied, using cells from 
normal persons and from those who are suspected of having 
heritable heightened susceptibility to DNA damage. 
This group was among the first to use psoralens and long-wave 
UV irradiation to treat patients with psoriasis. By carefully 
monitoring psoralen blood levels, it has been possible to modify 
photo-treatment times to match maximum skin photosensitivity. 
Clearer understanding of psoralen metabolism is the result. 
Endocrinology 
This laboratory was only recently organized by Professor Jack 
Fishman, but the research it is engaged in is a continuation of 
work which has been going on for the past 25 years. The focus of 
interest is on the biology of the steroid hormones, with particular 
emphasis on their role in human physiology and pathophysiology. 
The laboratory has pioneered in the characterization of the 
biosynthetic and metabolic pathways of the steroidal hormones in 
man and has been instrumental in establishing that their 
metabolic transformations are not solely catabolic in nature, but 
that the biological properties of the metabolites are of major 
consequence in the expression of hormone action. In the course 
of these studies, entire new categories of natural steroids have 
been identified, among them the catechol estrogens and the 
cortoic acids. The former are now known to exhibit unique central 
properties and are under intensive examination for their role in 
the control of pituitary hormone release in the human. The 
differential biological properties of steroid metabolites give 
emphasis to the changes in their formation that are associated 
with certain diseases. The existence of specific and distinct 
perturbations of steroid hormone metabolism have now been 
documented in several diseases. 
Investigations are also concerned with the impact of diet, 
drugs, and other environmental agents on hormone 
biotransformation in man, in the expectation that changes in the 
latter are responsible for some of the physiological effects of these 
factors. The role of estrogen metabolism in human reproduction 
and its involvement in the etiology of breast and endometrial 
cancer are also u�der intensive study. 
The clinical investigations have their counterpart in laboratory 
studies directed at the biochemical mechanisms of hormone 
biosynthesis and transformation, and at the nature of their 
biological action in appropriate target tissues, including the 
central nervous system. 
Human Behavior and Metabolism 
The laboratory of Professor Jules Hirsch and colleagues utilizes 
the findings of behavioral science, metabolism, and endocrinology 
to understand the nature of human obesity and the manner in 
which man and animals control food intake and energy 
metabolism. This laboratory has pioneered in the demonstration 
that obese subjects, even after reducing their weight, show 
persistent abnormalities in adipose cellularity, with an excess 
number of small adipocytes when compared to nonobese subjects. 
The reduced obese also show behavioral abnormalities which 
resemble those described in starvation. Studies now in progress 
utilize subjects in the Rockefeller Hospital and in its outpatient 
departments, as well as a variety of animal models of obesity 
maintained in the Laboratory Animal Research Center at The 
Rockefeller University. 
Present areas of investigation include: 
a. Taste in three-day-old infants. The development of sweet
taste in man and its relationship to food intake and body size. 
b. Adipose tissue metabolism, studied in vitro with adipose
tissue aspirates. The effect of cell size on sensitivity to lipolytic 
agents. 
c. Changes in hypothalamic-pituitary function as a result of
weight loss. Measures of TSH and ACTH, as well as insulin, 
growth hormone, and cholecystokinin, in man and experimental 
animals. 
d. The effect of lipectomy, high caloric intake, and early
infantile feeding on the cellularity and behavior of obese and 
normal rodents. 
Studies currently beginning are the effect of diet and adipose 
tissue composition on serum lipid level and on immune function, 
and the �ffect of weight reduction in man on thermogenesis and 
autonomic function. 
Lipid and Lipoprotein Metabolism. 
This laboratory, initiated in 1952 by Professor Edward H. Ahrens, 
Jr., has engaged in studies of lipid and lipoprotein metabolism in 
man: effects of various dietary fats on plasma lipid and 
lipoprotein levels, milk fat composition, erythrocyte lipids, and 
adipose tissue composition; effects of carbohydrate/fat exchanges 
on plasma lipids; absorption of fat by the intestine; mechanistic 
studies of lipid-lowering drugs. These studies depended on the 
development and refinement of new methods for use with 
patients as well as in the laboratory, including the first application 
of gas-liquid chromatography in this country; the measurement of 
intestinal lengths under physiological conditions; the sampling of 
adipose tissue by needle aspiration; the measurement of biliary 
lipid flow rates; and the introduction of orally fed liquid formulas 
for research. 
For the last 15 years, this group has focused on sterol 
metabolism in man. By developing and refining the sterol balance 
technique and by combining it with studies of isotope kinetics, it 
has become possible to measure the key regulatory factors 
governing the movement of cholesterol in, through, and out of 
the body, and thus to understand the mode of action of dietary 
and drug interventions aimed at reducing plasma and tissue lipid 
levels. These studies have demonstrated that individual patients 
respond very differently to diet/drug challenges. Present efforts of 
the laboratory are directed mainly to measuring the precision of 
feedback control of cholesterol synthesis in large numbers of 
outpatients, in order to tailor the management of hyperlipidemia 
to the pathogenetic defects in each person. 
The laboratory also is engaged in studies of cholesterol 
synthesis in mononuclear cells and in the intestinal mucosa; in 
defining the kinetics of mevalonate metabolism in man and in 
laboratory animals; in studies of sterol metabolism in patients 
maintained solely by total parenteral nutrition; and in a wide 
variety of functional studies of changes in membrane fluidity 
effected by the feeding of saturated and polyunsaturated fats. 
Medical Biochemistry 
The objective of this laboratory, established in 1971 by Professor 
Anthony Cerami, is to apply the knowledge of chemistry to 
understand the pathogenesis of diseases and to develop drugs to 
treat them. The major areas of research are diabetes and aging, 
parasitology, and genetic diseases. 
The purpose of the diabetes research is to ensure understand­
ing of the biochemical mechanism of the disease's many sequelae 
and to develop ways to prevent these complications. Studies on 
the biochemical basis of the sequelae have led to the concept that 
glucose can chemically react with body proteins in a nonenzymatic 
manner, and that the higher the glucose concentration, the 
greater the reaction. As a result of these findings, the degree of 
carbohydrate control can be monitored in diabetic patients. This is 
accomplished by assessing the amount of sugar-hemoglobin com­
ponent (hemoglobinA 1J, which in turn gives a measure of the 
previous month's integrated blood glucose concentration. A 
method of measuring glyco-peptides found in urine has been 
developed. As a result of studies on nonenzymatic reactions, the 
concept of a delivery system capable of supplying insulin to the 
body as a function of glucose concentration was developed, and a 
practical apparatus is in progress. 
Significant work has been done on cataract formation and 
peripheral neuropathy, the two major complications associated 
with diabetes, and an increased amount of reaction of glucose with 
important proteins in both the lens and peripheral nerve has been 
found. 
New drugs have been found for the parasitic diseases trypano­
somiasis, leishmaniasis, and filariasis. An in-depth study of host­
to-parasite response is of prime importance in understanding the 
basic disease processes. 
Pharmacological agents for treating genetic diseases have been 
emphasized in this laboratory. New agents for sickle-cell anemia, 
thalassemia, and cystic fibrosis are now being evaluated. 
Metabolism-Pharmacology 
The laboratory of Professor Attallah Kappas focuses on 
biochemical and clinical problems involving the oxygen-binding 
pigment heme; the pathways by which it is synthesized and 
degraded; and the various roles which heme plays in cellular 
metabolism and the biotransformation of such natural and foreign 
chemicals as hormones, drugs, and environmental pollutants. 
The main diseases under intensive investigation are the 
human porphyrias, which, in one form or another, result from 
genetic aberrations in activities of the various enzymes in 
porphyrin and heme production. Certain acquired disorders of 
heme metabolism, such as metal poisoning, and some drug 
intoxications are also being studied. The general approach is to 
examine- at the biochemical level and in a number of 
tissue-culture or animal-model systems- the factors that regulate 
heme and heme-protein (cytochrome P450) metabolism, and to 
translate the findings of such studies to the human situation when 
that is feasible and useful. 
Laboratory investigations relevant to the main interests of the 
group include the manner in which metals regulate the 
degradation of heme in tissue-cultured liver cells and in the 
organs of whole animals; the adaptations which take place in vivo
to protect against the detrimental effects of environmental 
chemicals, especially trace and heavy metals; means for 
controlling the activity of heme-pathway enzymes in order to 
achieve selective biological effects involving heme synthesis or 
· degradation; and the development of sensitive analytical methods
for analysis of all products and intermediates of the heme
pathway. Thus, application of these methods to diagnostic use in
humans can be achieved, utilizing the smallest possible biological
samples.
A newly developing interest of the laboratory group is the role 
of nutritional factors in regulating drug, hormone, and other 
chemical biotransformations. 
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